tradingkey.logo

Heartflow Inc

HTFL
27.740USD
+1.750+6.73%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
2.32BCap. mercado
PérdidaP/E TTM

Más Datos de Heartflow Inc Compañía

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Información de Heartflow Inc

Símbolo de cotizaciónHTFL
Nombre de la empresaHeartflow Inc
Fecha de salida a bolsaAug 08, 2025
Director ejecutivoFarquhar (John C. M)
Número de empleados699
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 08
Dirección331 E Evelyn Avenue
CiudadMOUNTAIN VIEW
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94041
Teléfono16502411221
Sitio Webhttps://www.heartflow.com/
Símbolo de cotizaciónHTFL
Fecha de salida a bolsaAug 08, 2025
Director ejecutivoFarquhar (John C. M)

Ejecutivos de Heartflow Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-471.00%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
+40000.00%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
+34246.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
+16447.00%
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John C. M. Farquhar
Mr. John C. M. Farquhar
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Julie Cullivan
Ms. Julie Cullivan
Independent Director
Independent Director
--
--
Mr. Tim Barabe
Mr. Tim Barabe
Independent Director
Independent Director
--
--
Dr. Wayne Riley, M.D.
Dr. Wayne Riley, M.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-471.00%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
+40000.00%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
+34246.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
+16447.00%
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United states
42.95M
92.80%
United kingdom
1.52M
3.28%
Japan
1.46M
3.16%
Rest of europe
349.00K
0.75%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: dom., 8 de feb
Actualizado: dom., 8 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Bain Capital Life Sciences Investors, LLC
12.27%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
Otro
64.11%
Accionistas
Accionistas
Proporción
Bain Capital Life Sciences Investors, LLC
12.27%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
Otro
64.11%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
51.66%
Investment Advisor/Hedge Fund
12.52%
Hedge Fund
3.17%
Individual Investor
2.46%
Endowment Fund
0.37%
Bank and Trust
0.32%
Private Equity
0.18%
Sovereign Wealth Fund
0.15%
Pension Fund
0.14%
Otro
29.04%

Participación institucional

Actualizado: mié., 21 de ene
Actualizado: mié., 21 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q4
129
59.51M
43.48%
--
2025Q4
149
60.27M
70.78%
+21.99M
2025Q3
46
45.42M
54.46%
+42.91M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Bain Capital Life Sciences Investors, LLC
12.45M
14.62%
--
--
Sep 30, 2025
HealthCor Partners Management LP
6.70M
7.86%
--
--
Sep 30, 2025
Wellington Management Company, LLP
4.88M
5.73%
+465.57K
+10.55%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.62M
5.42%
+1.33M
+40.42%
Sep 30, 2025
Capricorn Investment Group LLC
3.92M
4.61%
+3.92M
--
Aug 08, 2025
Hayfin Capital Management LLP
3.64M
4.27%
-1.00
-0.00%
Sep 30, 2025
Baillie Gifford & Co.
3.01M
3.53%
+415.89K
+16.06%
Sep 30, 2025
Schusterman Interests LLC
1.94M
2.28%
+1.94M
--
Sep 30, 2025
The Vanguard Group, Inc.
1.45M
1.7%
+285.27K
+24.45%
Sep 30, 2025
Capital International Investors
1.30M
1.52%
+1.30M
--
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
TrueShares Technology, AI & Deep Learning ETF
3.13%
Global X HealthTech ETF
1.75%
Fidelity Blue Chip Growth ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.06%
iShares Health Innovation Active ETF
0.02%
Schwab U.S. Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Schwab U.S. Broad Market ETF
0%
TrueShares Technology, AI & Deep Learning ETF
Proporción3.13%
Global X HealthTech ETF
Proporción1.75%
Fidelity Blue Chip Growth ETF
Proporción0.07%
T Rowe Price Small-Mid Cap ETF
Proporción0.06%
iShares Health Innovation Active ETF
Proporción0.02%
Schwab U.S. Small-Cap ETF
Proporción0.02%
Fidelity Nasdaq Composite Index ETF
Proporción0.01%
Schwab U.S. Broad Market ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI